Ibutilide-Induced Cardioversion of Atrial Fibrillation During Pregnancy

  1. RADKA KOCKOVA M.D.,
  2. VIKTOR KOCKA M.D.,
  3. THOMAS KIERNAN M.B., M.R.C.P.I.,
  4. GERARD J. FAHY M.D., F.R.C.P.I.

Article first published online: 7 FEB 2007

DOI: 10.1111/j.1540-8167.2006.00752.x

Issue

Journal of Cardiovascular Electrophysiology

Journal of Cardiovascular Electrophysiology

Volume 18, Issue 5, pages 545–547, May 2007

Additional Information

How to Cite

KOCKOVA, R., KOCKA, V., KIERNAN, T. and FAHY, G. J. (2007), Ibutilide-Induced Cardioversion of Atrial Fibrillation During Pregnancy. Journal of Cardiovascular Electrophysiology, 18: 545–547. doi: 10.1111/j.1540-8167.2006.00752.x

Author Information

  1. Department of Cardiology, South-Infirmary Victoria Hospital, Cork, Ireland

*Address for correspondence: Gerard J. Fahy, M.D., Consultant Cardiologist, Department of Cardiology, South-Infirmary Victoria Hospital, Old Blackrock Road, Cork, Ireland. Fax. +353214926306; E-mail: fahysdsl@eircom.net

  1. Manuscript received 10 July 2006; Revised manuscript received 20 November 2006; Accepted for publication 21 November 2006.

Publication History

  1. Issue published online: 7 FEB 2007
  2. Article first published online: 7 FEB 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (86K)

Keywords:

  • atrial fibrillation;
  • cardioversion;
  • ibutilide;
  • pregnancy;
  • teratogenicity

We present two cases of successful cardioversion of atrial fibrillation using intravenous ibutilide during pregnancy. One patient had atrial fibrillation, complicating the Wolff-Parkinson-White syndrome and the other had a history of nonobstructive hypertrophic cardiomyopathy. No adverse maternal or fetal effects were observed during or after pregnancy in either case.

View Full Article (HTML) Get PDF (86K)